Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Recep Tayyip Erdogan University Training and Research Hospital

Status: Completed

Conditions: Polycystic Ovary Syndrome

Treatments: Diagnostic Test: preptin and amylin level

Study type: Observational

Funder types: Other

Identifiers

NCT03587415

107

Details and patient eligibility

About

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Full description

Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (<25 kg/m2 and ≥25 kg/m2).

Enrollment: 80 patients

Sex: Female

Ages: 17 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

the patients with PCOS

Exclusion criteria

Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol

Trial design

80 participants in 2 patient groups

Polycyctic ovary sendrome (PCOS)

Description:

these women who have PCOS, we will use their blood samples

Treatment:

Diagnostic Test: preptin and amylin level

Healty groups

Description:

These women who have reguler menstrual cycle, no akne or hirsutism, we will use their boold samples

Treatment:

Diagnostic Test: preptin and amylin level